ifosfamide has been researched along with Neoplasms, Nerve Sheath in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prognosis of metastatic malignant peripheral nerve sheath tumor (MPNST) is poor and the role of chemotherapy is controversial." | 1.56 | Metastatic Malignant Peripheral Nerve Sheath Tumor With NF1 Successfully Treated With 'Gradual Subtraction' ICE Chemotherapy. ( Kakuda, Y; Katagiri, H; Miyagi, M; Murata, H; Takahashi, M; Wang, Y; Wasa, J, 2020) |
| "Malignant peripheral nerve sheath tumors (MPNST) are rare soft-tissue sarcomas with a tendency for recurrence and metastasis." | 1.37 | Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy. ( Crawford, EA; Lackman, RD; Moretti, VM; Ogilvie, CM; Staddon, AP, 2011) |
| " In the previous five cycles of ifosfamide, carboplatin, and etoposide, the patient had no problems with the neurotoxic adverse effects associated with ifosfamide use." | 1.35 | Possible contribution of aprepitant to ifosfamide-induced neurotoxicity. ( Jarkowski, A, 2008) |
| " The bioavailability is nearly 100% after oral application, and the main metabolites are 4-hydroxytrofosfamide, and 4-hydroxyifosfamide." | 1.32 | Hypersensitivity pneumonitis associated with the use of trofosfamide. ( Hartmann, JT; Kanz, L; Kopp, HG, 2004) |
| "Malignant peripheral nerve sheath tumors (MPNST) are uncommon tumors of cells of peripheral nerve sheath origin." | 1.32 | Intraosseous malignant peripheral nerve sheath tumor (MPNST) of the thoracic spine: a rare cause of spinal cord compression. ( Bhattacharjee, S; Gnanalingham, K; O'Neill, K, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, T | 1 |
| Sahu, S | 1 |
| Sharma, MC | 1 |
| Borkar, S | 1 |
| Wang, Y | 1 |
| Katagiri, H | 1 |
| Murata, H | 1 |
| Wasa, J | 1 |
| Miyagi, M | 1 |
| Kakuda, Y | 1 |
| Takahashi, M | 1 |
| Pannu, AK | 1 |
| Sharma, N | 1 |
| Jarkowski, A | 1 |
| Zambrana, F | 1 |
| Vicente, F | 1 |
| García-Manrique, T | 1 |
| Pereira, S | 1 |
| Sáinz De Zaitigui, J | 1 |
| De La Cruz Merino, L | 1 |
| Moretti, VM | 1 |
| Crawford, EA | 1 |
| Staddon, AP | 1 |
| Lackman, RD | 1 |
| Ogilvie, CM | 1 |
| Cuneo, KC | 1 |
| Riedel, RF | 1 |
| Dodd, LG | 1 |
| Harpole, DH | 1 |
| Kirsch, DG | 1 |
| Masui, F | 1 |
| Yokoyama, R | 1 |
| Soshi, S | 1 |
| Beppu, Y | 1 |
| Asanuma, K | 1 |
| Fujii, K | 1 |
| Kopp, HG | 1 |
| Kanz, L | 1 |
| Hartmann, JT | 1 |
| Gnanalingham, K | 1 |
| Bhattacharjee, S | 1 |
| O'Neill, K | 1 |
| Schafmayer, C | 1 |
| Egberts, JH | 1 |
| Kovács, G | 1 |
| Leuschner, I | 1 |
| Tepel, J | 1 |
11 other studies available for ifosfamide and Neoplasms, Nerve Sheath
| Article | Year |
|---|---|
Primary intradural extramedullary spinal Burkitt's lymphoma mimicking a nerve sheath tumor: a case report.
Topics: Burkitt Lymphoma; Cytarabine; Humans; Ifosfamide; Male; Middle Aged; Nerve Sheath Neoplasms; Treatme | 2022 |
Metastatic Malignant Peripheral Nerve Sheath Tumor With NF1 Successfully Treated With 'Gradual Subtraction' ICE Chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; M | 2020 |
Neurofibromatosis type 1 and disseminated malignant peripheral nerve sheath tumor.
Topics: Antineoplastic Agents; Cafe-au-Lait Spots; Disease Management; Doxorubicin; Humans; Ifosfamide; Lung | 2017 |
Possible contribution of aprepitant to ifosfamide-induced neurotoxicity.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Dexamet | 2008 |
Primary intracranial malignant peripheral nerve sheath tumour responding to chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Doxorubicin; Humans; Ifosfam | 2010 |
Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; | 2011 |
Pathologic complete response of a malignant peripheral nerve sheath tumor in the lung treated with neoadjuvant Ifosfamide and radiation therapy.
Topics: Antineoplastic Agents, Alkylating; Female; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Neoadjuv | 2012 |
A malignant peripheral nerve-sheath tumour responding to chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Cyclophosphamide; Doxorubicin; Hum | 2004 |
Hypersensitivity pneumonitis associated with the use of trofosfamide.
Topics: Administration, Oral; Aged; Alveolitis, Extrinsic Allergic; Antineoplastic Combined Chemotherapy Pro | 2004 |
Intraosseous malignant peripheral nerve sheath tumor (MPNST) of the thoracic spine: a rare cause of spinal cord compression.
Topics: Antineoplastic Combined Chemotherapy Protocols; Back Pain; Biopsy; Chemotherapy, Adjuvant; Combined | 2004 |
[Emergent treatment of a malignant peripheral epineurial tumour].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemo | 2006 |